葛蘭素史克 GSK
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 49.04 | 0.31 | 1,506,000 | 636 | ||
| 2025Q3 | 43.16 | 0.98 | 2,593,000 | 2,013 | ||
| 2025Q2 | 38.40 | 0.70 | 2,023,000 | 1,443 | ||
| 2025Q1 | 38.74 | 0.79 | 2,216,000 | 1,624 | ||
| 2024Q4 | 33.82 | 0.20 | 2,217,000 | 414 | ||
| 2024Q3 | 40.88 | -0.03 | 189,000 | -58 | ||
| 2024Q2 | 38.50 | 0.57 | 1,646,000 | 1,173 | ||
| 2024Q1 | 42.87 | 0.51 | 1,490,000 | 1,046 | ||
| 2023Q4 | 37.06 | 0.17 | 1,173,000 | 350 | ||
| 2023Q3 | 36.25 | 0.71 | 1,949,000 | 1,464 | ||
| 2023Q2 | 35.64 | 0.64 | 2,141,000 | 1,624 | ||
| 2023Q1 | 35.58 | 0.73 | 2,082,000 | 1,490 | ||
| 2022Q4 | 35.14 | 0.73 | 2,164,000 | 1,461 | ||
| 2022Q3 | 29.43 | 5.29 | 1,191,000 | 10,353 | ||
| 2022Q2 | 54.41 | 0.33 | 1,081,000 | 838 | ||
| 2022Q1 | 54.45 | 0.89 | 2,801,000 | 1,802 | ||
| 2021Q4 | 55.13 | 0.37 | 1,377,000 | 749 | ||
| 2021Q3 | 47.76 | 0.47 | 1,938,000 | 1,168 | ||
| 2021Q2 | 49.78 | 0.56 | 1,675,000 | 1,395 | ||
| 2021Q1 | 44.61 | 0.43 | 1,693,000 | 1,073 |